On April 6th, the China Association of Pharmaceutical Materials held the fifth session of the Fourth Standing Council in Hangzhou. At this meeting, Jiangxi Angtai Pharmaceutical Co., Ltd. was elected as the executive director unit of China Pharmaceutical Materials Association, and Chairman Ding Dalin was elected as the executive director of the fifth council.

Established in 1989, China Medical Materials Association is a national, non-profit social organization first-level legal person organization registered with the Ministry of Civil Affairs of the People's Republic of China. Its business supervisory unit is the State-owned Assets Supervision and Administration Commission of the State Council. [The association has more than 3,500 member units, including more than 500 pharmaceutical industrial and commercial enterprises, more than 800 chain pharmacies, more than 1,500 individual pharmacies, more than 500 authentic medicinal materials, traditional Chinese medicine and natural medicine, medical research and information services, etc. More than 200 members. The election of Angtai Pharmaceutical Co., Ltd. as the executive director unit of the 5th Council of China Pharmaceutical Materials Association is the affirmation of the company's development strength by China Pharmaceutical Materials Association, and it is of great significance to the future development.